Meor Mohd Redzuan Meor Mohd Affandi

Meor Mohd Redzuan Meor Mohd Affandi

Auto-generated profile, based on publicly available information

Meor Mohd Redzuan Meor Mohd Affandi

Faculty of Pharmacy, Universiti Teknologi MARA, Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam,Selangor Darul Ehsan, Malaysia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Nutritional Neuroscience
Verified
Journal Article
Closed access
ASA. S. Mohd Shafie
A. S. Mohd Shafie
SKS. N. Kamarudin
S. N. Kamarudin
MAM. M. R. Meor Mohd Affandi
M. M. R. Meor Mohd Affandi
RSRos Siran
Ros Siran
Carotenoids are naturally occurring bio-pigments found in microalgae, plants, fungi, bacteria, and various aquatic animals. They are generally classified into carotenes and xanthophylls based on their structural features. Among them, astaxanthin-a xanthophyll carotenoid-has attracted increasing attention due to its potent antioxidant, anti-inflammatory, and anti-apoptotic properties, which contribute to a range of health benefits. This review highlights the structural features, physicochemical properties, pharmacokinetics, and therapeutic potential of astaxanthin, particularly focusing on its neuroprotective effects in neurological disorders. To provide a comprehensive overview, we systematically searched published articles across Scopus, Google Scholar, PubMed, and Medline databases from inception to January 1, 2025. Recent advancements in drug formulation and delivery technologies have enhanced astaxanthin's ability to cross the blood-brain barrier (BBB), significantly increasing its potential as a therapeutic agent for neurological diseases. With its multifaceted biological effects and growing evidence of neuroprotection, astaxanthin shows great promise in the treatment of neurological disorders, particularly stroke. These findings support its future development and application in pharmaceutical strategies aimed at brain health.

1 December 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
NWNur Rafiqah Abdol Wahab
Nur Rafiqah Abdol Wahab
MAMeor Mohd Redzuan Meor Mohd Affandi
Meor Mohd Redzuan Meor Mohd Affandi
SFSharida Fakurazi
Sharida Fakurazi
EAEkram Alias
Ekram Alias
HHHaniza Hassan
Haniza Hassan
Introduction: The xanthophyll carotenoid astaxanthin is well-known for its potent antioxidant properties, which are superior to those of other antioxidants such as vitamins C and E. However, this highly hydrophobic compound has low solubility and poor oral bioavailability, limiting its efficacy and clinical application. To address these pharmacokinetic challenges, nanostructured lipid carriers (NLC) have been proposed as potential lipid-based drug carriers for the oral delivery of astaxanthin owing to their excellent biocompatibility, stability, and efficient drug loading capacity. Purpose: In this study, we aimed to develop an NLC using cocoa butter and palm oil for astaxanthin encapsulation, and to optimize the nanoformulation by employing Response Surface Methodology (RSM), a statistical approach. Methods: Three-factor Central Composite Design (CCD) in RSM was used to understand the effect of independent variables on response variables. The size, polydispersity index, and encapsulation efficiency of the astaxanthin-loaded NLC were also characterized. Results: Findings of this study indicated that the mass of cocoa butter, palm oil and Tween 80 influenced the particle size, polydispersity index and zeta potential of NLC. The experimental determination of NLC did not differ significantly from the predicted RSM outcomes with size, polydispersity index and zeta potential of 254.42 ± 3.91 nm, 0.38 ± 0.01 and − 30.54 ± 0.85 mV, respectively. This nanoparticulate system showed an excellent astaxanthin entrapment efficiency of 99.69± 0.0003%. Conclusion: The ideal combination of each composition in the NLC formulation yielded nanoparticles with desirable particle size, polydispersity index, and zeta potential for efficient oral delivery of astaxanthin. Plain Language Summary: Astaxanthin is a natural antioxidant that is much stronger than vitamins C and E. However, it does not dissolve well in water and is poorly absorbed when administered orally, which limits its usefulness. To overcome this drawback, this study explored the use of nanostructured lipid carriers (NLC), which are tiny fat-based particles, to improve astaxanthin movement in the body. An NLC formulation was developed using cocoa butter and palm oil. The optimization process was conducted using a statistical method called Response Surface Methodology (RSM) to determine the best combination of ingredients. Different amounts of cocoa butter, palm oil, and a stabilizer (Tween 80) can affect the size, stability, and ability of the particles to hold astaxanthin. The results also showed that the optimized NLC had a small and uniform size (approximately 254 nm), stable dispersion (zeta potential of − 30.54 mV), and highly efficient astaxanthin trapping (99.69%). In conclusion, we successfully developed an NLC formulation that can efficiently carry astaxanthin, potentially improving its absorption and effectiveness when used as a supplement or medicine.

6 April 2026 in Discover Food
Verified
Journal Article
Open access
PDF file
ZZZainul Amiruddin Zakaria
Zainul Amiruddin Zakaria
MBMohammad Amil Zulhilmi Benjamin
Mohammad Amil Zulhilmi Benjamin
NNNur Liana Md Nasir
Nur Liana Md Nasir
HMHUSSIN MUHAMMAD
HUSSIN MUHAMMAD
LSLilis Sulistyorini
Lilis Sulistyorini
MAMuhammad Nazrul Hakim Abdullah
Muhammad Nazrul Hakim Abdullah
Growing demand for Schizophyllum commune Fr. reflects its pharmaceutical and nutraceutical potential, although its safety profile remains underexplored despite long-standing traditional use. This study aimed to evaluate the in vitro cytotoxicity, in vivo acute and subacute oral toxicity, and mycochemical composition of the aqueous extract of S. commune (AESC). Cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on human gastric adenocarcinoma (AGS) and human hepatocellular carcinoma (HepG2) cell lines. Acute toxicity was evaluated in Sprague-Dawley rats given a single oral dose of 5000 mg/kg bw, while subacute toxicity involved daily oral doses of 250, 500, and 1000 mg/kg bw for 28 days. Parameters including clinical signs, body weight, relative organ weight, food and water intake, and haematological, biochemical, and histopathological changes were monitored throughout the study. Mycochemical characterisation was performed using qualitative screening tests and liquid chromatography–quadrupole time-of-flight mass spectrometry (LC–QTOF–MS). The MTT assay indicated minimal cytotoxicity, with half-maximal inhibitory concentration (IC50) values exceeding 1000 µg/mL for both AGS and HepG2 cells. No mortality or adverse signs occurred in the acute toxicity study, indicating a median lethal dose (LD50) greater than 5000 mg/kg bw. Similarly, the subacute study showed no adverse effects at any tested dose in either sex, with a no-observed-adverse-effect level (NOAEL) greater than 1000 mg/kg bw. Qualitative screening revealed no detectable levels of major secondary metabolite classes, while LC–QTOF–MS profiling identified amino acids, fatty acids, and low-abundance phenolic compounds as the predominant constituents of AESC. These findings confirm a favourable safety profile of AESC, supporting further evaluation for gastro- and hepato-protective applications.

8 July 2026 in Discover Food
Verified
Journal Article
Open access
PDF file
ZZZainul Amiruddin Zakaria
Zainul Amiruddin Zakaria
MBMohammad Amil Zulhilmi Benjamin
Mohammad Amil Zulhilmi Benjamin
NNNur Liana Md Nasir
Nur Liana Md Nasir
HMHUSSIN MUHAMMAD
HUSSIN MUHAMMAD
LSLilis Sulistyorini
Lilis Sulistyorini
MAMuhammad Nazrul Hakim Abdullah
Muhammad Nazrul Hakim Abdullah

1 September 2026 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SHSabrina Mohamed Hasnol
Sabrina Mohamed Hasnol
MAMeor Mohd Redzuan Meor Mohd Affandi
Meor Mohd Redzuan Meor Mohd Affandi
TWTin Wui Wong
Tin Wui Wong
NANor Khaizan Anuar
Nor Khaizan Anuar
Introduction: Transdermal delivery of prednisolone using solid-lipid nanoparticles (SLN) offers a promising strategy to enhance drug administration by enabling direct transport through the skin into the systemic circulation. However, the impact of processing conditions on the physicochemical properties and release mechanisms of prednisolone‑loaded SLN remains insufficiently explored. Methods: The present study developed prednisolone-loaded SLN using an emulsification–homogenization– ultrasonication approach. Key process parameters, namely homogenization stirring speed and duration, as well as ultrasonication time, temperature, and power, were systematically refined based on particle size, polydispersity index (PDI), and zeta potential. The selected formulation was further characterized for entrapment efficiency (EE), drug loading (DL), attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and in vitro drug release. Results: The experimentally determined DL ranged from 8.52 ± 0.55 to 9.89 ± 1.73%, corresponding to 85-99% of the intended loading, indicating minimal processing loss. Formulation H3, selected for further characterization based on its physicochemical profile, was homogenized at 10,000 rpm for 4 minutes, followed by ultrasonication at 60°C and 60 W for 4 minutes. H3 exhibited a particle size of 319.00 ± 56.15 nm, a PDI of 0.48 ± 0.022, a zeta potential of −19.86 ± 9.56 mV, and an EE of 98.25 ± 0.49%. All formulations demonstrated sustained drug release over 24 h with no statistically significant differences observed among them (p = 0.148). Discussion: Kinetic modeling showed that both Higuchi and Korsmeyer–Peppas models adequately described the release profile of H3, suggesting heterogeneous release behavior involving overlapping diffusion- and matrix- related mechanisms. ATR-FTIR and DSC analyses indicated alterations in intermolecular interactions and lipid packing behavior following nanoparticle formation, while TEM confirmed spherical morphology and absence of visible aggregation, consistent with successful formation of the SLN system. conclusion: This study suggested prednisolone-loaded SLN as a potential transdermal drug delivery system, with sustained drug release profiles. Conclusion: Prednisolone-loaded SLN prepared using emulsification–homogenization–ultrasonication demonstrated favorable physicochemical properties and sustained release behavior governed by combined diffusion and matrix-related processes. Further studies on long-term stability, as well as ex vivo and in vivo skin permeation, are required to confirm their suitability for transdermal application.